These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 36094343

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Amelioration of Parkinson's disease by pharmacological inhibition and knockdown of redox sensitive TRPC5 channels: Focus on mitochondrial health.
    Vaidya B, Gupta P, Laha JK, Roy I, Sharma SS.
    Life Sci; 2023 Sep 01; 328():121871. PubMed ID: 37352915
    [Abstract] [Full Text] [Related]

  • 3. 2-Aminoethoxydiphenyl borate ameliorates mitochondrial dysfunctions in MPTP/MPP+ model of Parkinson's disease.
    Vaidya B, Polepalli M, Sharma SS, Singh JN.
    Mitochondrion; 2023 Mar 01; 69():95-103. PubMed ID: 36758857
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Neuroprotective Effects of the DPP4 Inhibitor Vildagliptin in In Vivo and In Vitro Models of Parkinson's Disease.
    Pariyar R, Bastola T, Lee DH, Seo J.
    Int J Mol Sci; 2022 Feb 21; 23(4):. PubMed ID: 35216503
    [Abstract] [Full Text] [Related]

  • 6. Ginsenoside Rk1 prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease via activating silence information regulator 3-mediated Nrf2/HO-1 signaling pathway.
    Ren Y, Ye D, Ding Y, Wei N.
    Hum Exp Toxicol; 2023 Feb 21; 42():9603271231220610. PubMed ID: 38105596
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Anti-apoptotic effect of modified Chunsimyeolda-tang, a traditional Korean herbal formula, on MPTP-induced neuronal cell death in a Parkinson's disease mouse model.
    Li H, Park G, Bae N, Kim J, Oh MS, Yang HO.
    J Ethnopharmacol; 2015 Dec 24; 176():336-44. PubMed ID: 26593210
    [Abstract] [Full Text] [Related]

  • 9. TRPM2 Promotes Neurotoxin MPP+/MPTP-Induced Cell Death.
    Sun Y, Sukumaran P, Selvaraj S, Cilz NI, Schaar A, Lei S, Singh BB.
    Mol Neurobiol; 2018 Jan 24; 55(1):409-420. PubMed ID: 27957685
    [Abstract] [Full Text] [Related]

  • 10. Therapeutic effects of multifunctional tetramethylpyrazine nitrone on models of Parkinson's disease in vitro and in vivo.
    Guo B, Xu D, Duan H, Du J, Zhang Z, Lee SM, Wang Y.
    Biol Pharm Bull; 2014 Jan 24; 37(2):274-85. PubMed ID: 24305623
    [Abstract] [Full Text] [Related]

  • 11. Pharmacological Modulation of TRPM2 Channels via PARP Pathway Leads to Neuroprotection in MPTP-induced Parkinson's Disease in Sprague Dawley Rats.
    Vaidya B, Kaur H, Thapak P, Sharma SS, Singh JN.
    Mol Neurobiol; 2022 Mar 24; 59(3):1528-1542. PubMed ID: 34997907
    [Abstract] [Full Text] [Related]

  • 12. Hippocampal damage and white matter lesions contribute to cognitive impairment in MPTP-lesioned mice with chronic cerebral hypoperfusion.
    Gao Y, Tang H, Nie K, Zhu R, Gao L, Feng S, Wang L, Zhao J, Huang Z, Zhang Y, Wang L.
    Behav Brain Res; 2019 Aug 05; 368():111885. PubMed ID: 30959125
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of Potential Neuroprotective Effects of Vanillin Against MPP+/MPTP-Induced Dysregulation of Dopaminergic Regulatory Mechanisms in SH-SY5Y Cells and a Mouse Model of Parkinson's Disease.
    Rani L, Ghosh B, Ahmad MH, Mondal AC.
    Mol Neurobiol; 2023 Aug 05; 60(8):4693-4715. PubMed ID: 37145378
    [Abstract] [Full Text] [Related]

  • 14. Therapeutic activation of autophagy by combined treatment with rapamycin and trehalose in a mouse MPTP-induced model of Parkinson's disease.
    Pupyshev AB, Tikhonova MA, Akopyan AA, Tenditnik MV, Dubrovina NI, Korolenko TA.
    Pharmacol Biochem Behav; 2019 Feb 05; 177():1-11. PubMed ID: 30582934
    [Abstract] [Full Text] [Related]

  • 15. Neuroprotective effects of Eucommia ulmoides Oliv. and its bioactive constituent work via ameliorating the ubiquitin-proteasome system.
    Guo H, Shi F, Li M, Liu Q, Yu B, Hu L.
    BMC Complement Altern Med; 2015 May 21; 15():151. PubMed ID: 25994206
    [Abstract] [Full Text] [Related]

  • 16. Overexpression of TFAM, NRF-1 and myr-AKT protects the MPP(+)-induced mitochondrial dysfunctions in neuronal cells.
    Piao Y, Kim HG, Oh MS, Pak YK.
    Biochim Biophys Acta; 2012 May 21; 1820(5):577-85. PubMed ID: 21856379
    [Abstract] [Full Text] [Related]

  • 17. RIPK1 inhibitor ameliorates the MPP+/MPTP-induced Parkinson's disease through the ASK1/JNK signalling pathway.
    Liu J, Hu H, Wu B.
    Brain Res; 2021 Apr 15; 1757():147310. PubMed ID: 33524379
    [Abstract] [Full Text] [Related]

  • 18. Impairment of Nrf2- and Nitrergic-Mediated Gastrointestinal Motility in an MPTP Mouse Model of Parkinson's Disease.
    Sampath C, Kalpana R, Ansah T, Charlton C, Hale A, Channon KM, Srinivasan S, Gangula PR.
    Dig Dis Sci; 2019 Dec 15; 64(12):3502-3517. PubMed ID: 31187328
    [Abstract] [Full Text] [Related]

  • 19. Neuroprotective effects of Suhexiang Wan on the in vitro and in vivo models of Parkinson's disease.
    Liu Q, Sang Heon K, Yung-Wei S, Sok Cheon P, Wonwoong L, Jongki H, Jaehwan J, Kyoung Sang C, Songhee J, Byung-Soo K.
    J Tradit Chin Med; 2019 Dec 15; 39(6):800-808. PubMed ID: 32186150
    [Abstract] [Full Text] [Related]

  • 20. A cell-permeable peptide inhibitor TAT-JBD reduces the MPP+-induced caspase-9 activation but does not prevent the dopaminergic degeneration in substantia nigra of rats.
    Pain S, Barrier L, Deguil J, Milin S, Piriou A, Fauconneau B, Page G.
    Toxicology; 2008 Jan 14; 243(1-2):124-37. PubMed ID: 18037221
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.